Rchr
J-GLOBAL ID:200901050847964265   Update date: Sep. 06, 2024

Fukushima Tsuyoshi

フクシマ ツヨシ | Fukushima Tsuyoshi
Affiliation and department:
Job title: Associate Professor
Homepage URL  (1): http://www.med.miyazaki-u.ac.jp/patho2/index.html
Research field  (4): Molecular biology ,  Human pathology ,  Neurosurgery ,  Experimental pathology
Research keywords  (1): Life science
Research theme for competitive and other funds  (12):
  • 2017 - 現在 Multifaceted approach for understanding of malignant phenotype of glioblastoma
  • 2021 - 2022 脳腫瘍の発生・増殖・浸潤に関する分子病理学的解析
  • 2019 - 2020 脳腫瘍の発生・増殖・浸潤に関する分子病理学的解析
  • 2016 - 2017 脳腫瘍の浸潤・増殖を制御する分子機構の解析
  • 2012 - 2016 Regulation of protease activities on the epithelial cell surface and its significance in epithelial disorders.
Show all
Papers (85):
  • 木脇 拓道, 川口 真紀子, 片岡 寛章, 福島 剛. LRP11は肺腺癌の予後不良と関連する(Low-density lipoprotein receptor related protein 11(LRP11) contributes to poor prognosis in lung adenocarcinoma). 日本癌学会総会記事. 2023. 82回. 1397-1397
  • Makiko Kawaguchi, Hiroaki Kataoka, Takumi Kiwaki, Weiting Liang, Sayaka Nagata, Kazuo Kitamura, Tsuyoshi Fukushima. Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin-4 expression in the colonic epithelium. FEBS Open Bio. 2023
  • 川口 真紀子, 木脇 拓道, 福島 剛, 片岡 寛章. マトリプターゼ欠損は大腸発癌を誘発し、Claudin-7の局在異常をもたらす(Loss of matriptase leads to colorectal carcinogenesis and causes abnormal localization of Claudin-7 in tumor cells). 日本癌学会総会記事. 2022. 81回. P-2088
  • 福島 剛, 川口 真紀子, 木脇 拓道, 片岡 寛章. MGMTメチル化以外の膠芽腫の抗がん剤耐性機序(Mechanism of chemoresistance to temozolomide besides MGMT status in glioblastoma cells). 日本癌学会総会記事. 2022. 81回. P-2303
  • Fumiki Yamashita, Takashi Kaieda, Takeshi Shimomura, Makiko Kawaguchi, Chen-Yong Lin, Michael D Johnson, Hiroyuki Tanaka, Takumi Kiwaki, Tsuyoshi Fukushima, Hiroaki Kataoka. Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor-1. The FEBS Journal. 2022. 289. 12. 3422-3439
more...
MISC (18):
  • Tsuyoshi Fukushima, Shuichiro Uchiyama, Hiroyuki Tanaka, Hiroaki Kataoka. Hepatocyte growth factor activator; a proteinase linking tissue injury with repair. International Journal of Molecular Sciences. 2018. 19. 11. 3435-3435
  • Kataoka H, Kawaguchi M, Fukushima T, Shimomura T. Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): emerging key players in epithelial integrity and cancer. Pathology International. 2018. 68. 3. 145-158
  • 赤木 真由美, 西村 豊樹, 池田 俊郎, 布井 博幸, 梅北 佳子, 福島 剛, 田中 弘之, 秋山 裕, 片岡 寛章. 劇症肝障害を呈したインフルエンザ脳症の一剖検例. 日本病理学会会誌. 2017. 106. 1. 417-417
  • 福島剛, 横山貴裕, 山下真治, 横上聖貴, 竹島秀雄, 梅北佳子, 秋山裕, 赤木真由美, 田中弘之, 片岡寛章. 肥胖細胞と退形成性変化が著明であった悪性星芽腫の一例. 日本病理学会会誌. 2017. 106. 1
  • Tsuyoshi Fukushima, Jingjia Ye, Makiko Kawaguchi, Yukihiro Haruyama, Ai Kanemaru, Koji Yamamoto, Hiroaki Kataoka. Silencing of membrane-bound serine protease inhibitor, HAI-1, enhances metastatic capability of pancreatic cancer cells in mouse models. CLINICAL & EXPERIMENTAL METASTASIS. 2015. 32. 3. 202-202
more...
Books (2):
  • Chaptor 5; Alkylating Agents and Treatment of Gliomas. In: Yildiz Dincer eds. Alkylating Agents as Environmental Carcinogen and Chemotherapy Agents
    Nova Science Publishers, Inc. 2013 ISBN:9781626184879
  • Chapter 19: Insulin-Like Growth Factor Binding Protein-2: A Possible Regulator of Invasive Growth in Glioblastoma. In: Miklos Grami eds. Molecular Targets of CNS Tumors
    InTech 2011 ISBN:9789533077369
Lectures and oral presentations  (147):
  • An autopsy case of brain tumor accompanied by systemic metastasis: a difficulty in discrimination between glioblastoma and small cell carcinoma
    (The 40th Annual Meeting of Japanese Human Cell Society 2022)
  • Mechanism of chemoresistance to temozolomide besides MGMT status in glioblastoma cells
    (第81回日本癌学会学術総会 2022)
  • A case of brain tumor accompanied by systemic metastasis with bone marrow carcinomatosis
    (The 31st Meeting of the Japanese Association for Metastasis Research 2022)
  • AT/RT 6例の臨床病理学的検討
    (第40回日本脳腫瘍病理学会 2022)
  • Exploratory research for novel functional genes in glioblastoma
    (The 39th Annual Meeting of Japan Human Cell Society 2021)
more...
Education (2):
  • - 2007 University of Miyazaki Graduate School, Division of Medical Sciences
  • - 1996 Miyazaki Medical College Faculty of Medicine
Work history (10):
  • 2021/07 - 現在 University of Miyazaki Faculty of Medicine School of Medicine Department of Pathology, Oncopathology and Regenerative Biology Associate Professor
  • 2007/08 - 2021/06 University of Miyazaki Faculty of Medicine School of Medicine Department of Pathology, Oncopathology and Regenerative Biology Assistant Professor
  • 2007/04/01 - 2007/07/31 University of Miyazaki Faculty of Madicine School of Madicine Pathology course tumor and reproduction condition study field Assistant Professor
  • 2003/04/01 - 2007/07/31 University of Miyazaki Faculty of Madicine School of Madicine Pathology course tumor and reproduction condition study field Graduate student(doctorate program)
  • 2002/04/01 - 2003/03/31 医療法人青雲会青雲病院 医師(脳神経外科)
Show all
Committee career (11):
  • 2023/07 - 現在 The Japan ese Association for Cancer Metastasis Research Director
  • 2021/05 - 現在 日本脳腫瘍病理学会 評議員
  • 2021/04 - 現在 日本病理学会 学術評議員
  • 2017/04/01 - 現在 日本ヒト細胞学会 評議員
  • 2017/04 - 現在 日本ヒト細胞学会 理事
Show all
Awards (2):
  • 2013/08/11 - 日本ヒト細胞学会 第31回日本ヒト細胞学会学術集会ポスター発表賞
  • 2012/07/12 - 日本がん転移学会 日本がん転移学会研究奨励賞
Association Membership(s) (13):
International Academy of Pathology, Japanese Division ,  The Japanese Society of Clinical Cytology ,  The Japanese Association for Metastasis Research ,  The Japanese Human Cell Society ,  American Association for Cancer Research ,  The Japanese Society of Pathology ,  Japanese Cancer Association ,  Japan Neurosurgical Society ,  The Japan Society for Clinical Laboratory Automation ,  Japanese Congress of Neurological Surgeons ,  The Molecular Biology Society of Japan ,  日本脳腫瘍病理学会 ,  The Japan Society of Molecular Neurosurgery
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page